AgingResearch.NewsJoin free

Lipoprotein(a) and fibrinogen

Biomarker

3 papers mention it1 finding

See all 3 papers on lipoprotein(a) and fibrinogen

“Participants with both elevated Lp(a) and fibrinogen levels demonstrated the highest 20-year ASCVD risk (HR 1.904, 95%CI [1.023, 3.547]).”
The interplay of fibrinogen and lipoprotein(a) with 20-year atherosclerotic cardiovascular disease risk: a path analysis within the ATTICA study (2002-2022)European journal of preventive cardiology2026doi:10.1093/eurjpc/zwag337

Associations

1

Atherosclerotic cardiovascular disease incidence

upin humans1HR 1.904

1 study

  1. Lipoprotein(a) and fibrinogen is associated with atherosclerotic cardiovascular disease incidence in humans (jointly elevated lipoprotein(a) and fibrinogen) (HR 1.904, 95% CI 1.023–3.547).

    “Participants with both elevated Lp(a) and fibrinogen levels demonstrated the highest 20-year ASCVD risk (HR 1.904, 95%CI [1.023, 3.547]).”

    Humansjointly elevated lipoprotein(a) and fibrinogen20 years

    The interplay of fibrinogen and lipoprotein(a) with 20-year atherosclerotic cardiovascular disease risk: a path analysis within the ATTICA study (2002-2022)

    European journal of preventive cardiology

More on Atherosclerotic cardiovascular disease incidence

Latest